Alexandre Vasiljevic
Overview
Explore the profile of Alexandre Vasiljevic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
2920
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deligne C, Tourbez A, Benard F, Meyer S, Curt A, Gianesello M, et al.
Neuro Oncol
. 2025 Jan;
PMID: 39792378
Background: Brain tumors are the deadliest solid tumors in children and adolescents. Most of these tumors are glial in origin and exhibit strong heterogeneity, hampering the development of effective therapeutic...
2.
Filser M, Torrejon J, Merchadou K, Dufour C, Girard E, Bourneix C, et al.
Neuro Oncol
. 2024 Dec;
PMID: 39731757
Background: Medulloblastoma (MB) is one of the most prevalent embryonal malignant brain tumors. Current classification organizes these tumors into four molecular subgroups (WNT, SHH, Group 3, and Group 4 MB)....
3.
Gupta A, Kasaliwal R, Das L, Sharma S, Kaur V, Vasiljevic A, et al.
Front Endocrinol (Lausanne)
. 2024 Oct;
15():1473167.
PMID: 39449742
Acromegaly due to ectopic secretion of growth hormone-releasing hormone (GHRH) is a rare disorder. The signs and symptoms of ectopic acromegaly are indistinguishable from acromegaly due to a somatotroph adenoma....
4.
Huchede P, Meyer S, Berthelot C, Hamadou M, Bertrand-Chapel A, Rakotomalala A, et al.
Elife
. 2024 Oct;
12.
PMID: 39373720
Pediatric diffuse midline gliomas (pDMG) are an aggressive type of childhood cancer with a fatal outcome. Their major epigenetic determinism has become clear, notably with the identification of K27M mutations...
5.
De Alcubierre D, Gkasdaris G, Mordrel M, Joncour A, Briet C, Almairac F, et al.
Eur J Endocrinol
. 2024 Aug;
191(2):251-261.
PMID: 39158090
Objective: Targeted therapy (TT) with BRAF/MEK inhibitors has emerged as a potential treatment in papillary craniopharyngiomas (PCPs). However, standardized data on large cohorts are lacking. Our study aimed to assess...
6.
Liu A, Li B, Vasiljevic A, Dewan M, Tamrazi B, Ertl-Wagner B, et al.
Neuro Oncol
. 2024 Jul;
26(12):2159-2173.
PMID: 39073785
Pineal parenchymal tumors are rare neoplasms for which evidence-based treatment recommendations are lacking. These tumors vary in biology, clinical characteristics, and prognosis, requiring treatment that ranges from surgical resection alone...
7.
Cuny T, Reynaud R, Raverot G, Coutant R, Chanson P, Kariyawasam D, et al.
Ann Endocrinol (Paris)
. 2024 Jul;
86(1):101631.
PMID: 39002896
No abstract available.
8.
Pannier E, Sekri A, Roux N, Vasiljevic A, El Khattabi L, Chatron N, et al.
Birth Defects Res
. 2024 Jul;
116(7):e2380.
PMID: 38980211
Background: Fontaine progeroid syndrome (FPS, OMIM 612289) is a recently identified genetic disorder stemming from pathogenic variants in the SLC25A24 gene, encoding a mitochondrial carrier protein. It encompasses Gorlin-Chaudry-Moss syndrome...
9.
Birtolo M, Jouinot A, Vasiljevic A, Boulagnon-Rombi C, Asioli S, Bousdira G, et al.
Virchows Arch
. 2024 Jun;
485(3):407-415.
PMID: 38907774
The aim of this multicenter prospective survey called PIT-EASY was to assess the relevance of the European Pituitary Pathology Group (EPPG) diagnostic tools for pituitary neuroendocrine tumors (PitNETs) to improve...
10.
Garrido E, Ngoc H, Guyotat J, Pelissou-Guyotat I, Jacquesson T, Delabar V, et al.
Cancers (Basel)
. 2024 Apr;
16(7).
PMID: 38610939
The aim was to identify predictors of progression in a series of patients managed for an intracranial hemangioblastoma, in order to guide the postoperative follow-up modalities. The characteristics of 81...